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 
Abstract— Lymph node metastasis (LNM) is a significant 
prognostic factor in patients with head and neck cancer, and the 
ability to predict it accurately is essential for treatment 
optimization. PET and CT imaging are routinely used for LNM 
identification. However, uncertainties of LNM always exist 
especially for small size or reactive nodes. Radiomics and deep 
learning are the two preferred imaging-based strategies for 
node malignancy prediction. Radiomics models are built based 
on handcrafted features, and deep learning can learn the 
features automatically. We proposed a hybrid predictive model 
that combines many-objective radiomics (MO-radiomics) and 
3-dimensional convolutional neural network (3D-CNN) through 
evidential reasoning (ER) approach. To build a more reliable 
model, we proposed a new many-objective radiomics model. 
Meanwhile, we designed a 3D-CNN that fully utilizes spatial 
contextual information. Finally, the outputs were fused through 
the ER approach. To study the predictability of the two 
modalities, three models were built for PET, CT, and PET&CT. 
The results showed that the model performed best when the two 
modalities were combined. Moreover, we showed that the 
quantitative results obtained from the hybrid model were better 
than those obtained from MO-radiomics and 3D-CNN.   
I. INTRODUCTION 
Head and neck (H&N) cancer is the sixth most common 
cancer type worldwide [1]. Since one third of the body’s 
lymph nodes are located in the head and neck, lymph node 
metastases (LNM) is one of the most important metastatic 
ways for malignant tumors and are a significant prognostic 
factor for patients with H&N cancer [2]. Clinically, CT and 
PET have been routinely used for LNM identification. CT is 
used commonly for detection purposes, and PET has the great 
advantages of location and histological nature of the LNM [3]. 
Although some lymph nodes are clearly positive due to their 
large size or high activity on PET-CT, there is often significant 
uncertainty about the malignant potential of lymph nodes in 
H&N cancer.  
Imaging-based classification is solved by two major 
strategies: handcrafted feature-based models and feature 
learning-based models. Among the handcrafted feature 
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models, radiomics appears to be a highly promising solution 
[4]. Defined as the extraction and analysis of a large number 
of quantitative features, radiomics has been applied 
successfully to solve various prediction problems, such as 
treatment outcome prediction [5], and survival analysis [6]. 
Huang et al. [7] developed a radiomics model to predict LNM 
in colorectal cancer. The features were extracted from CT 
images, and multivariable logistic regression was used to 
build the predictive model. To build a more reliable model, 
our group developed a multi-objective radiomics model [8] 
which considered both sensitivity and specificity as the 
objective functions. For feature learning-based models, deep 
learning is a powerful method that has been used to predict 
outcomes in cancer therapy. Sung et al. [9] described the use 
of deep learning methods such as the convolutional neural 
network (CNN), deep belief network, and stacked de-noising 
auto-encoder  to predict  lung nodule malignancy. Zhu et al. 
designed a new CNN model to predict survival in lung cancer 
[10]. Yang et al. [11] built a model that combined the 
recurrent neural network and multinomial hierarchical 
regression decoder to predict breast cancer metastasis.   
As both handcrafted feature and feature learning models 
have yielded promising results, one challenge from a practical 
point of view is to determine which model is more suitable to 
predict LNM. Manually extracted features and automatic 
learned features are complementary [12], and therefore may 
yield more stable results. Therefore, a strategy that combines 
both handcrafted and learning models is a more suitable 
choice to predict LNM. 
In this work, we proposed a hybrid model that combines the 
multi-objective radiomics and 3D-CNN through evidential 
reasoning (ER) to predict LNM in H&N cancer. Because the 
multi-objective model [8] can only handle binary problems, 
we proposed a new MO-radiomics model that can predict the 
three classes of lymph nodes- normal, suspicious, and 
involved. Other than using sensitivity and specificity as the 
objectives in multi-objective model, procedure accuracy (PA) 
and user accuracy (UA) in confusion matrix (CM) were 
considered simultaneously as objectives in the proposed 
model. We adopted CNN [13], one of the most effective 
feature learning models consisting of conventional, max 
pooling, and fully connected layers. Since the nodes appear in 
3D in the images, a 3D-CNN model was designed to consider 
spatial contextual information. The final output was obtained 
by fusing MO-radiomics and 3D-CNN model outputs through 
the ER approach [14]. ER was originally proposed to deal with 
multiple attribute decision analysis problems with both 
qualitative and quantitative attributes under uncertainty. Also, 
ER can yield the more reliable fusing results.  
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Figure 1. Workflow of the proposed hybrid model.
II. MATERIALS AND METHODS  
A. Patient dataset 
The study included 31 patients with H&N cancer who had 
enrolled in the involved field trial between 2016 and 2017 at 
UT Southwestern Medical Center. Pretreatment PET and CT 
images were exported from picture archiving and 
communication system. Nodal status was reviewed for all trial 
patients by a radiation oncologist and a nuclear medicine 
radiologist. Involved and suspicious nodes were contoured on 
contrast-enhanced CT under the guidance of PET. The lymph 
nodes for the first 21 patients were used for model training, 
including 53 involved nodes, 39 suspicious nodes, and 30 
normal nodes. Then, the predictive model was validated on the 
remaining independent 10 patients with 13 involved nodes, 9 
suspicious nodes, and 17 normal nodes. A total of 122 nodes 
were used for training and 39 were used for testing. 
B. Model overview 
The workflow of the hybrid model is illustrated in Figure 
1. First, the extracted nodes were input into the 3D-CNN and 
MO-radiomics model. Then, the two model outputs were 
fused by ER to obtain the final output.   
C. MO-radiomics model 
In MO-radiomics, image features including intensity, 
texture, and geometric are extracted from the contoured lymph 
nodes (involved and suspicious) in PET and CT images. 
Additionally, at least one normal LN of similar size to the 
suspicious lymph nodes was contoured to train the predictive 
model for each patient. Intensity features include minimum, 
maximum, mean, standard deviation, sum, median, skewness, 
kurtosis, and variance. Geometry features include volume, 
major diameter, minor diameter, eccentricity, elongation 
orientation, bounding box volume, and perimeter. Texture 
features are based on 3D gray-level co-occurrence and are 
extracted as follows: energy, entropy, correlation, contrast, 
texture variance, sum-mean, inertia, cluster shade, cluster 
prominence, homogeneity, max-probability, and inverse 
variance. A total of 257 features were extracted for each PET 
and CT, respectively.  
Then we used the support vector machine to build the 
predictive model with parameters denoted by 𝛼 =
{𝛼1, ⋯ , 𝛼𝑀}, where 𝑀 is the number of model parameters. All 
features including PET and CT imaging features are denoted 
by 𝛽 = {𝛽1, ⋯ , 𝛽𝑁}, where 𝑁 is the number of features. PAs 
and UAs in CM were taken as objective functions because of 
the three classes of lymph nodes. We maximized 𝑓𝑃𝐴
𝑖  and 𝑓𝑈𝐴
𝑖  
simultaneously to obtain the Pareto-optimal set:  
𝑓 = max𝛼,𝛽(𝑓𝑃𝐴
𝑖 , 𝑓𝑈𝐴
𝑖 , 𝑖 = 1,2,3).                 (1) 
where 𝑓𝑃𝐴
𝑖 , 𝑓𝑈𝐴
𝑖 represent the objective functions of PA and 
UA, respectively where 𝑓𝑃𝐴
𝑖 , 𝑓𝑈𝐴
𝑖 represent the objective 
functions of PA and UA, respectively. According to equation 
(1), six objective functions were used. The final solution of the 
selected features and model parameters can be selected from 
the Pareto-optimal set according to different clinical needs. 
 To solve the optimization problem defined in equation (1), 
we developed a many-objective optimization algorithm based 
on our previous multi-objective algorithm [8]. The proposed 
algorithm also consists of two phases: (1) Pareto-optimal 
solution generation; (2) best solution selection. The first phase 
is same as that of the multi-objective algorithm [8], which 
includes initialization, clonal operation, mutation operation, 
deleting operation, population update, and termination 
detection. In the second phase, the final solution is selected 
according to accuracy and area under the curve (AUC). 
Assume that the thresholds for accuracy are denoted by 𝑇𝑎𝑐𝑐 . 
The Pareto-optimal solution is denoted 
by  𝐷 = {𝐷1, 𝐷2, ⋯ , 𝐷𝑃} . The corresponding accuracy and 
AUC for each individual 𝐷𝑖 , 𝑖 = 1, 2, ⋯ , 𝑃  are denoted by 
𝐷𝑖
𝑎𝑐𝑐 , 𝐷𝑖
𝐴𝑈𝐶 , 𝑖 = 1,2, ⋯ , 𝑃 , respectively. The procedure to 
select the best solution is as follows: Step 1) For each solution 
set 𝐷𝑖 , 𝑖 = 1,2, ⋯ , 𝑃 , if 𝐷𝑖
𝑎𝑐𝑐 > 𝑇𝑎𝑐𝑐 , Di  is selected. All 
selected candidates constitute the new candidate set denoted 
by 𝐷𝐶 = {𝐷𝐶
1 , 𝐷𝐶
2, ⋯ , 𝐷𝐶
𝑄} , where 𝑄  is the number of the 
selected individual, i.e., feasible solutions. Step 2) The final 
solution 𝑃∗ is selected with the highest AUC in 𝐷𝐶 . 
D. 3D-CNN model 
The architecture of the proposed 3D-CNN model includes 
12 convolutional layers, 2 max pooling layers, and 2 fully 
connected layers (Figure 1). Each convolutional layer is 
equipped with rectified linear unit (ReLU) activation [15] and 
batch normalization. The construction order of different kinds 
of layers in the architecture is shown in Table I. 
Since the max-pooling layer provides basic translation 
invariance to the internal representation, the convolutional and 
max-pooling layers are arranged alternately in the proposed 
architecture. In addition, with the help of the max-pooling 
layer which down-samples the feature maps, the convolutional 
layers in the architecture can capture both local and global 
features. In the proposed architecture, the first 8 convolutional 
layers are unpadded and the last 4 are padded to deeply extract 
and analyze features of the 3D image. To prevent 
back-propagated gradients from vanishing or exploding, we 
used Xavier initialization and categorical cross entropy loss 
  
function to train the proposed model. If we use CT or PET 
imaging only, the 3D-CNN input is a volumetric image. If we 
use PET and CT simultaneously, the input consists of two 
volumetric images, each serving as a channel of the final 4D 
data input. Data augmentation by rotating 3D images and 
Synthetic Minority Over-sampling technique [16] is used to 
balance and increase training samples. The network produces 
three probabilities for each class. 
TABLE I.  3D-CNN ARCHITECTURE 
Layer Kernel Size Stride Output Size Features Volumes 
Input -  48×48×32 1(or 2) 
C1 5×5×5 [1 1 1] 44×44×28 64 
C2 3×3×3 [1 1 1] 42×42×26 64 
C3 3×3×3 [1 1 1] 40×40×24 64 
C4 3×3×3 [1 1 1] 38×38×22 64 
C5 3×3×3 [1 1 1] 36×36×20 64 
MP1 2×2×2 [2 2 2] 18×18×10 64 
C6 3×3×3 [1 1 1] 16×16×8 64 
C7 2×2×2 [1 1 1] 15×15×5 64 
C8 3×3×3 [1 1 1] 13×13×4 64 
MP2 3×3×3 [2 2 2] 6×6×2 64 
C9 3×3×3 [1 1 1] 6×6×2 64 
C10 3×3×1 [1 1 1] 6×6×2 64 
C11 3×3×1 [1 1 1] 6×6×2 64 
C12 3×3×1 [1 1 1] 6×6×2 32 
FC1   1×1×1 256 
FC2     1×1×1 3 
*C indicates Convolution layer + ReLU layer +Batch Normalization layer; 
MP indicates Max-pooling layer; GAP indicates Global-average-pooling layer 
and FC indicates Fully-connected layer. 
E. ER fusion 
After obtaining the outputs from the two models, the final 
output is generated using ER. Assume that 𝑃1 = {𝑝1
1, 𝑝2
1, 𝑝3
1} 
represents the output of MO-radiomics, and the 3D-CNN 
output is denoted by 𝑃2 = {𝑝1
2, 𝑝2
2, 𝑝3
2} . They satisfy the 
following constraint: 
∑ 𝑃𝑖
𝑗 = 1,   3𝑖=1 0 ≤ 𝑃𝑖
𝑗 ≤ 1, 𝑗 = 1,2,                  (2) 
Before using ER fusion, the weight 𝜔 = {𝜔1, 𝜔2} , which 
satisfies 𝜔1 + 𝜔2 = 1, 0 ≤ 𝜔𝑗 ≤ 1, needs to be calculated. In 
this work, 𝜔 is calculated based on accuracy in the training 
stage. Assume that the accuracy for the two trained models is 
𝐴𝑗, 𝑗 = 1,2, 𝜔𝑗 is: 
𝜔𝑗 =
𝐴𝑗
∑ 𝐴𝑗
2
𝑗=1
, 𝑗 = 1,2,                             (3) 
The final output 𝑃𝑖 , 𝑖 = 1,2,3  is obtained through the 
following Equations: 
             𝑃𝑖 =
𝜇×[∏ (𝜔𝑗𝑃𝑖
𝑗
+1−𝜔𝑗 ∑ 𝑃𝑖
𝑗𝑀
𝑖=1 )−∏ (1−𝜔𝑗 ∑ 𝑃𝑖
𝑗𝑀
𝑖=1 )
𝑁
𝑗=1
𝑁
𝑗=1 ]
1−𝜇×[∏ (1−𝜔𝑗)
𝑁
𝑗=1 ]
, (4) 
             𝜇 = [∑ ∏ (𝜔𝑗𝑃𝑖
𝑗 + 1 − 𝜔𝑗 ∑ 𝑃𝑖
𝑗𝑀
𝑖=1 ) − (𝑁 −
𝑁
𝑗=1
𝑀
𝑖=1
                       1) ∏ (1 − 𝜔𝑗 ∑ 𝑃𝑖
𝑗𝑀
𝑖=1 )
𝑁
𝑗=1 ]
−1
,                          (5)                
where 𝑀 = 3, 𝑁 = 2. Finally, the label 𝐿 is obtained by: 
𝐿 = max(𝑃𝑖).                                 (6) 
III. RESULTS  
Besides combining PET and CT as input, we also used 
PET and CT alone to build the predictive models. Two typical 
radiomics (Radiomics) and CNN (XmaxNet) methods were 
also performed for comparison. For the many-objective 
training algorithm, the population number was set to 100, 
while the maximal generation number was set to 200. The 
mutation probability was set to 0.9 in the mutation operation. 
Five-cross-validation was used to train the model. Because 
three categories of nodules need to be handled, CM, accuracy, 
and multiclass AUC [17] were used to evaluate the 
performance. All the comparative results were statistical 
significance (p-value<0.01). The accuracy for five models 
under three situations is shown in Figure 2. Compared 
XmasNet and Radiomics with our proposed single and hybrid 
models, we demonstrated that the hybrid model can obtain the 
same or better accuracy. Although accuracy is the same as that 
of MO-radiomics and 3D-CNN in CT imaging, it improved in 
the hybrid model, indicating the effectiveness of ER fusion. 
The multiclass AUC shown in Figure 3 demonstrated that the 
hybrid model outperformed the four models, suggesting that 
results are more reliable after combination. On the other hand, 
improving the accuracy of LNM prediction in clinical use can 
predict overall survival and distant metastases more 
accurately. 
 
Figure 2. Accuracy for five models under three situations. 
 
Figure 3. AUC for five models under three situations. 
TABLE II.  CONFUSION MATRIX FOR MO-RADIOMICS 
 Node 
Predicted  
Normal 
Predicted 
Suspicious 
Predicted  
Involved UA 
CT 
Normal 17 0 0 1.00 
suspicious 3 2 4 0.22 
involved 1 1 11 0.85 
PA 0.89 0.67 0.73 
 
PET 
Normal 15 2 0 0.88 
suspicious 1 6 2 0.67 
involved 2 0 11 0.85 
PA 0.83 0.75 0.85 
 
PET 
& CT 
Normal 17 0 0 1.00 
suspicious 1 5 3 0.56 
involved 1 0 12 0.92 
PA 0.90 1.00 0.80   
  
TABLE III.  CONFUSION MATRIX FOR 3D-CNN 
 Node 
Predicted 
Normal 
Predicted 
Suspicious 
Predicted 
Involved UA 
CT 
Normal 14 3 0 0.82 
suspicious 2 5 2 0.56 
involved 2 0 11 0.86 
PA 0.78 0.63 0.85 
 
PET 
Normal 17 0 0 1.00 
suspicious 0 3 6 0.33 
involved 2 0 11 0.85 
PA 0.90 1 0.65 
 
PET 
& 
CT 
Normal 16 1 0 0.94 
suspicious 0 9 0 1.00 
involved 2 1 10 0.77 
PA 0.89 0.82 1.00   
CM results for the MO-radiomics model under three 
situations is shown in Table II, and those for 3D-CNN are 
shown in Table III. The CM for the proposed hybrid model is 
shown in table IV. All three CMs show that normal and 
involved nodes are easier to predict than suspicious nodes 
probably because suspicious and involved nodes are too 
similar to differentiate. When PET and CT are combined, 
better PA and UA can be obtained. Moreover, the hybrid 
model can yield the best PA and UA. Overall, our proposed 
predictive model is more effective than two single models in 
predicting LNM. 
TABLE IV.  CONFUSION MATRIX FOR HYBRID MODEL 
 
Node 
Predicted  
Normal 
Predicted  
Suspicious 
Predicted  
Involved UA 
CT 
Normal 16 1 0 0.94 
suspicious 2 4 3 0.44 
involved 1 1 11 0.85 
PA 0.84 0.67 0.79 
 
PET 
Normal 16 1 0 0.94 
suspicious 1 5 3 0.56 
involved 2 0 11 0.85 
PA 0.84 0.83 0.79 
 
PET 
& 
CT 
Normal 16 1 0 0.94 
suspicious 0 9 0 1 
involved 2 0 11 0.85 
PA 0.89 0.90 1.00   
IV. CONCLUSION 
We proposed a hybrid model that predicts LNM in H&N 
cancer by combining MO-radiomics and 3D-CNN fused by 
the ER approach. To obtain more reliable performance, a new 
MO-radiomics model was developed based on our previous 
work, in which PAs and UAs in CM are considered as 
objective functions. Meanwhile, a 3D-CNN model was 
developed to make full use of contextual information in the 
images. The final output was obtained by combining the two 
model outputs using the ER approach. Our experimental 
results showed that the proposed model that combines PET 
and CT outperformed the two single models and classic 
methods.   
   In the MO-radiomics model, PAs and UAs are optimized 
simultaneously. In fact, these two types of objective functions 
can be trained alternately, which can potentially further 
improve the model performance. To obtain a more robust 
model, the transfer learning can be introduced into the 
3D-CNN model as a next step. The dataset will also be 
expanded to include more patient data for building and 
validating the model so it can be applied successfully to 
clinical settings in the future.  
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